Niagen Bioscience Inc (NAGE) Stock Forecast
Data as of Aug 7, 2026Healthcare · Current price $3.00 (—)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
NAGE vs Sector & Market
| Metric | NAGE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 4 | 8 | 18 |
| Target Upside | +212.0% | +16315.9% | +17.2% |
| P/E Ratio | 13.75 | 3.40 | 35.26 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $146M | $148M | $150M | 4 |
| 2027-03-31 | $36M | $37M | $38M | 1 |
| 2027-06-30 | $40M | $41M | $42M | 2 |
| 2027-09-30 | $45M | $47M | $48M | 2 |
| 2027-12-31 | $46M | $47M | $49M | 1 |
| 2028-03-31 | $43M | $45M | $46M | 1 |
| 2028-06-30 | $49M | $50M | $52M | 1 |
| 2028-09-30 | $55M | $57M | $59M | 1 |
| 2028-12-31 | $56M | $58M | $60M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.16 | $0.27 | $0.37 | 3 |
| 2027-03-31 | $0.04 | $0.05 | $0.05 | 1 |
| 2027-06-30 | $0.07 | $0.08 | $0.08 | 1 |
| 2027-09-30 | $0.10 | $0.11 | $0.11 | 1 |
| 2027-12-31 | $0.10 | $0.10 | $0.11 | 1 |
| 2028-03-31 | $0.08 | $0.08 | $0.08 | 1 |
| 2028-06-30 | $0.11 | $0.12 | $0.13 | 1 |
| 2028-09-30 | $0.15 | $0.16 | $0.17 | 1 |
| 2028-12-31 | $0.14 | $0.15 | $0.16 | 1 |
Frequently Asked Questions
What is the analyst consensus for NAGE?
The consensus among 4 analysts covering Niagen Bioscience Inc (NAGE) is Buy with an average price target of $10.50.
What is the highest price target for NAGE?
The highest analyst price target for NAGE is $11.00.
What is the lowest price target for NAGE?
The lowest analyst price target for NAGE is $10.00.
How many analysts cover NAGE?
4 analysts have issued ratings for Niagen Bioscience Inc in the past 12 months.
Is NAGE a buy or sell right now?
Based on 4 analyst ratings, NAGE has a consensus rating of Buy (2.00/5) with a +212.0% upside to the consensus target of $10.50.
What are the earnings estimates for NAGE?
Analysts estimate NAGE will report EPS of $0.27 for the period ending 2026-12-31, with revenue estimated at $148M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.